Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Biological Drug CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Innovative Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biological Drug CDMO include Samsung Biologics, Lonza, Boehringer Ingelheim, Catalent, BioCentriq, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Recipharm and Delpharm, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Biological drug CDMO (Contract Development and Manufacturing Organization) is a company that specializes in the development and manufacturing of biological drugs. Biological drugs are complex molecules that are produced from living cells, and they include a wide range of products such as vaccines, monoclonal antibodies, and cell therapies.
This report aims to provide a comprehensive presentation of the global market for Biological Drug CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Drug CDMO. This report contains market size and forecasts of Biological Drug CDMO in global, including the following market information:
Global Biological Drug CDMO Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biological Drug CDMO companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Drug CDMO Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Biological Drug CDMO Market Segment Percentages, by Type, 2022 (%)
Innovative Drug
Listed Patent Drugs
Biosimilar
Global Biological Drug CDMO Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Biological Drug CDMO Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical Company
Biotechnology Company
Global Biological Drug CDMO Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Biological Drug CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biological Drug CDMO revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Biological Drug CDMO revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Samsung Biologics
Lonza
Boehringer Ingelheim
Catalent
BioCentriq
FUJIFILM Diosynth Biotechnologies
Thermo Fisher Scientific
Recipharm
Delpharm
Aenova
Siegfried
WuXi Biologics
Obio Technology
Hepalink
Pharmaron
ChemPartner
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biological Drug CDMO, market overview.
Chapter 2: Global Biological Drug CDMO market size in revenue.
Chapter 3: Detailed analysis of Biological Drug CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biological Drug CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Biological Drug CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biological Drug CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biological Drug CDMO Overall Market Size
2.1 Global Biological Drug CDMO Market Size: 2022 VS 2029
2.2 Global Biological Drug CDMO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biological Drug CDMO Players in Global Market
3.2 Top Global Biological Drug CDMO Companies Ranked by Revenue
3.3 Global Biological Drug CDMO Revenue by Companies
3.4 Top 3 and Top 5 Biological Drug CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies Biological Drug CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biological Drug CDMO Players in Global Market
3.6.1 List of Global Tier 1 Biological Drug CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 Biological Drug CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Biological Drug CDMO Market Size Markets, 2022 & 2029
4.1.2 Innovative Drug
4.1.3 Listed Patent Drugs
4.1.4 Biosimilar
4.2 By Type - Global Biological Drug CDMO Revenue & Forecasts
4.2.1 By Type - Global Biological Drug CDMO Revenue, 2018-2023
4.2.2 By Type - Global Biological Drug CDMO Revenue, 2024-2029
4.2.3 By Type - Global Biological Drug CDMO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biological Drug CDMO Market Size, 2022 & 2029
5.1.2 Pharmaceutical Company
5.1.3 Biotechnology Company
5.2 By Application - Global Biological Drug CDMO Revenue & Forecasts
5.2.1 By Application - Global Biological Drug CDMO Revenue, 2018-2023
5.2.2 By Application - Global Biological Drug CDMO Revenue, 2024-2029
5.2.3 By Application - Global Biological Drug CDMO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Biological Drug CDMO Market Size, 2022 & 2029
6.2 By Region - Global Biological Drug CDMO Revenue & Forecasts
6.2.1 By Region - Global Biological Drug CDMO Revenue, 2018-2023
6.2.2 By Region - Global Biological Drug CDMO Revenue, 2024-2029
6.2.3 By Region - Global Biological Drug CDMO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Biological Drug CDMO Revenue, 2018-2029
6.3.2 US Biological Drug CDMO Market Size, 2018-2029
6.3.3 Canada Biological Drug CDMO Market Size, 2018-2029
6.3.4 Mexico Biological Drug CDMO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Biological Drug CDMO Revenue, 2018-2029
6.4.2 Germany Biological Drug CDMO Market Size, 2018-2029
6.4.3 France Biological Drug CDMO Market Size, 2018-2029
6.4.4 U.K. Biological Drug CDMO Market Size, 2018-2029
6.4.5 Italy Biological Drug CDMO Market Size, 2018-2029
6.4.6 Russia Biological Drug CDMO Market Size, 2018-2029
6.4.7 Nordic Countries Biological Drug CDMO Market Size, 2018-2029
6.4.8 Benelux Biological Drug CDMO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Biological Drug CDMO Revenue, 2018-2029
6.5.2 China Biological Drug CDMO Market Size, 2018-2029
6.5.3 Japan Biological Drug CDMO Market Size, 2018-2029
6.5.4 South Korea Biological Drug CDMO Market Size, 2018-2029
6.5.5 Southeast Asia Biological Drug CDMO Market Size, 2018-2029
6.5.6 India Biological Drug CDMO Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Biological Drug CDMO Revenue, 2018-2029
6.6.2 Brazil Biological Drug CDMO Market Size, 2018-2029
6.6.3 Argentina Biological Drug CDMO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biological Drug CDMO Revenue, 2018-2029
6.7.2 Turkey Biological Drug CDMO Market Size, 2018-2029
6.7.3 Israel Biological Drug CDMO Market Size, 2018-2029
6.7.4 Saudi Arabia Biological Drug CDMO Market Size, 2018-2029
6.7.5 UAE Biological Drug CDMO Market Size, 2018-2029
7 Biological Drug CDMO Companies Profiles
7.1 Samsung Biologics
7.1.1 Samsung Biologics Company Summary
7.1.2 Samsung Biologics Business Overview
7.1.3 Samsung Biologics Biological Drug CDMO Major Product Offerings
7.1.4 Samsung Biologics Biological Drug CDMO Revenue in Global Market (2018-2023)
7.1.5 Samsung Biologics Key News & Latest Developments
7.2 Lonza
7.2.1 Lonza Company Summary
7.2.2 Lonza Business Overview
7.2.3 Lonza Biological Drug CDMO Major Product Offerings
7.2.4 Lonza Biological Drug CDMO Revenue in Global Market (2018-2023)
7.2.5 Lonza Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Biological Drug CDMO Major Product Offerings
7.3.4 Boehringer Ingelheim Biological Drug CDMO Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Catalent
7.4.1 Catalent Company Summary
7.4.2 Catalent Business Overview
7.4.3 Catalent Biological Drug CDMO Major Product Offerings
7.4.4 Catalent Biological Drug CDMO Revenue in Global Market (2018-2023)
7.4.5 Catalent Key News & Latest Developments
7.5 BioCentriq
7.5.1 BioCentriq Company Summary
7.5.2 BioCentriq Business Overview
7.5.3 BioCentriq Biological Drug CDMO Major Product Offerings
7.5.4 BioCentriq Biological Drug CDMO Revenue in Global Market (2018-2023)
7.5.5 BioCentriq Key News & Latest Developments
7.6 FUJIFILM Diosynth Biotechnologies
7.6.1 FUJIFILM Diosynth Biotechnologies Company Summary
7.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Major Product Offerings
7.6.4 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Revenue in Global Market (2018-2023)
7.6.5 FUJIFILM Diosynth Biotechnologies Key News & Latest Developments
7.7 Thermo Fisher Scientific
7.7.1 Thermo Fisher Scientific Company Summary
7.7.2 Thermo Fisher Scientific Business Overview
7.7.3 Thermo Fisher Scientific Biological Drug CDMO Major Product Offerings
7.7.4 Thermo Fisher Scientific Biological Drug CDMO Revenue in Global Market (2018-2023)
7.7.5 Thermo Fisher Scientific Key News & Latest Developments
7.8 Recipharm
7.8.1 Recipharm Company Summary
7.8.2 Recipharm Business Overview
7.8.3 Recipharm Biological Drug CDMO Major Product Offerings
7.8.4 Recipharm Biological Drug CDMO Revenue in Global Market (2018-2023)
7.8.5 Recipharm Key News & Latest Developments
7.9 Delpharm
7.9.1 Delpharm Company Summary
7.9.2 Delpharm Business Overview
7.9.3 Delpharm Biological Drug CDMO Major Product Offerings
7.9.4 Delpharm Biological Drug CDMO Revenue in Global Market (2018-2023)
7.9.5 Delpharm Key News & Latest Developments
7.10 Aenova
7.10.1 Aenova Company Summary
7.10.2 Aenova Business Overview
7.10.3 Aenova Biological Drug CDMO Major Product Offerings
7.10.4 Aenova Biological Drug CDMO Revenue in Global Market (2018-2023)
7.10.5 Aenova Key News & Latest Developments
7.11 Siegfried
7.11.1 Siegfried Company Summary
7.11.2 Siegfried Business Overview
7.11.3 Siegfried Biological Drug CDMO Major Product Offerings
7.11.4 Siegfried Biological Drug CDMO Revenue in Global Market (2018-2023)
7.11.5 Siegfried Key News & Latest Developments
7.12 WuXi Biologics
7.12.1 WuXi Biologics Company Summary
7.12.2 WuXi Biologics Business Overview
7.12.3 WuXi Biologics Biological Drug CDMO Major Product Offerings
7.12.4 WuXi Biologics Biological Drug CDMO Revenue in Global Market (2018-2023)
7.12.5 WuXi Biologics Key News & Latest Developments
7.13 Obio Technology
7.13.1 Obio Technology Company Summary
7.13.2 Obio Technology Business Overview
7.13.3 Obio Technology Biological Drug CDMO Major Product Offerings
7.13.4 Obio Technology Biological Drug CDMO Revenue in Global Market (2018-2023)
7.13.5 Obio Technology Key News & Latest Developments
7.14 Hepalink
7.14.1 Hepalink Company Summary
7.14.2 Hepalink Business Overview
7.14.3 Hepalink Biological Drug CDMO Major Product Offerings
7.14.4 Hepalink Biological Drug CDMO Revenue in Global Market (2018-2023)
7.14.5 Hepalink Key News & Latest Developments
7.15 Pharmaron
7.15.1 Pharmaron Company Summary
7.15.2 Pharmaron Business Overview
7.15.3 Pharmaron Biological Drug CDMO Major Product Offerings
7.15.4 Pharmaron Biological Drug CDMO Revenue in Global Market (2018-2023)
7.15.5 Pharmaron Key News & Latest Developments
7.16 ChemPartner
7.16.1 ChemPartner Company Summary
7.16.2 ChemPartner Business Overview
7.16.3 ChemPartner Biological Drug CDMO Major Product Offerings
7.16.4 ChemPartner Biological Drug CDMO Revenue in Global Market (2018-2023)
7.16.5 ChemPartner Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
